LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
Haotao Yu, Wei Zhou, Weiming Yan, Zhongqi Xu, Yinhao Xie, Ping Zhang Department of Orthopedics, Division 1, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou City, Guangdong Province 510000, People’s Republic of ChinaCorrespondence: Ping ZhangDepartment of Orthopedic...
Guardado en:
Autores principales: | Yu H, Zhou W, Yan W, Xu Z, Xie Y, Zhang P |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c5f4d9b029e54f229f3bb1f693c4bf75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway
por: Hsu,Wenchan, et al.
Publicado: (2019) -
Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis
por: Liu Z, et al.
Publicado: (2020) -
MicroRNA-151a-3p Functions in the Regulation of Osteoclast Differentiation: Significance to Postmenopausal Osteoporosis
por: He Y, et al.
Publicado: (2021) -
Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis
por: Paula Rackoff
Publicado: (2009) -
The predictive role of monocyte-lymphocyte ratio and plateletlymphocyte ratio in postmenopausal osteoporosis
por: Ibrahim Kale
Publicado: (2021)